StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of AMPE opened at $0.00 on Tuesday. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 2.21. The firm’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.56. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $7.47.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- What is a Low P/E Ratio and What Does it Tell Investors?
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
